期刊
BIOCHEMISTRY
卷 51, 期 32, 页码 6289-6311出版社
AMER CHEMICAL SOC
DOI: 10.1021/bi3006169
关键词
-
资金
- National Institute of General Medical Sciences
- National Institute of Neurological Disorders and Stroke
- American Health Assistance Foundation
- Glenn Foundation
Copper is a redox-active metal with many important biological roles. Consequently, its distribution and oxidation state are subject to stringent regulation. A large body of clinicopathological, circumstantial, and epidemiological evidence suggests that the dysregulation of copper is intimately involved in the pathogenesis of Alzheimer's disease. Other light transition metals such as iron and zinc may affect copper regulation by competing for copper binding sites and transporters. Therapeutic interventions targeting the regulation of copper are promising, but large gaps in our understanding of copper biochemistry, amyloidogenesis, and the nature of oxidative stress in the brain must be addressed.
作者
我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。
推荐
暂无数据